B. Pedras et al. / Inorganica Chimica Acta 381 (2012) 95–103
97
For the subsequent studies with DNA the same procedure was
adopted, by measuring at different [DNA]/[Ru] ratios and choosing
the ratio after which no significant changes in the emission spec-
trum and lifetime were observed to be studied with the selected
quenchers (ethidium bromide, potassium hexacyanoferrate(II)
and methyl viologen).
(Liquid film,
1017, 896, 738, 704. Mp = 241.0–242.2 °C. UV–Vis (ethanol, nm):
kmax (log ) = 364 (4.20).
m
/cmꢁ1): 3436, 1567, 1498, 1444, 1421, 1265, 1072,
e
2.3.1.4. 2-(50-Phenylfuran-20-yl)-1H-imidazo[4,5-f][1,10]phenanthro-
line (6c). The compound was isolated as a yellow solid (0.061 g,
1
60%). H NMR (400 MHz, DMSO-d6): d 7.23 (d, 1H, J = 3.6 Hz, 30-
2.3. Synthesis
H), 7.34–7.38 (m, 2H, 400-H + 40-H), 7.49 (t, 2H, J = 8.0 and 7.6 Hz,
300-H + 500-H), 7.80–7.83 (m, 2H, 5-H + 10-H), 7.91 (d, 2H,
J = 7.6 Hz, 200-H + 600-H), 8.93 (dd, 2H, J = 8.4 and 1.6 Hz, 4-H + 11-
H), 9.02 (dd, 2H, J = 6.0 and 1.6 Hz, 6-H + 9-H) ppm. 13C NMR
(100.6 MHz, DMSO-d6): d 108.4, 111.9, 121.6, 123.3, 123.9, 128.1,
128.9, 131.3, 131.3, 143.2, 143.6, 145.3, 147.8, 153.9 ppm. MS
(FAB): m/z (%) 363 ([M+H]+, 100). HRMS (FAB): m/z Calc. for
The precursor complex, namely cis-[Ru(bpy)2Cl2], was synthe-
sized according to literature methods [19]. The syntheses of li-
gands 4a and 4b have been previously reported [14a].
2.3.1. General procedure for the synthesis of imidazo[4,5-f][1,10]-
phenanthrolines 5 and 6
C
23H15N4O: 363.12380. Found: 363.12404. IR (Nujol, m
/cmꢁ1):
A mixture of the corresponding aldehyde (1.2 mmol), NH4OAc
(20 mmol) and 1,10-phenanthroline-5,6-dione (1 mmol) in glacial
acetic acid (10 mL) was stirred and heated at reflux for 5 h. The
mixture was then cooled to room temperature and the product
precipitated during neutralization with NH4OH 5 m. The precipi-
tate was filtered out, washed with water and diethyl ether, recrys-
tallized from absolute ethanol and dried under vacuum to give the
expected product.
3371, 2911, 2853, 1619, 1565, 1490, 1397, 1299, 1277, 1190,
1150, 1124, 1073, 1027, 924, 803, 758, 688. Mp = 243.4–244.9.
UV–Vis (ethanol, nm): kmax (log e) = 353 (4.48).
2.3.2. Synthesis of the Ru(II) complexes
In 5 mL of ethylene glycol, the corresponding quantity of imi-
dazo-phenanthroline ligand and the Ru(bpy)2Cl2 complex were
dissolved. The mixture was heated in a Milestone microwave oven
(450 W) for 30 s, which led to a color change from violet to deep
orange, and then allowed to cool for a while. The mixture was
heated for three more periods of 30 s. The solvent was removed
by distillation at low pressure, the residue was dissolved in 2 mL
of water, and a saturated NH4PF6 aqueous solution was added.
The precipitate formed was then filtered through a frit, washed
with water (3ꢀ 10 mL) and diethyl ether (3ꢀ 10 mL), and dried un-
der vacuum.
2.3.1.1.
2-(40-(Thien-200-yl)phen-20-yl)-1H-imidazo[4,5-f][1,10]phe-
nanthroline (5). Yellow solid (0.139 g, 82%). 1H NMR (300 MHz,
DMSO-d6): d 7.18–7.21 (m, 1H, 400-H), 7.62 (d, 1H, J = 5.1 Hz, 300-
H), 7.66 (d, 1H, J = 3.6 Hz, 500-H), 7.81–7.85 (m, 2H, 5-H and 10-
H), 7.90 (d, 2H, J = 8.7 Hz, 20-H and 60-H), 8.31 (d, 2H, J = 8.4 Hz,
30-H and 50-H), 8.92 (dd, 2H, J = 8.1 and 1.5 Hz, 4-H and 11-H),
9.03 (dd, 2H, J = 4.5 and 1.8 Hz, 6-H and 9-H), 13.79 (s, 1H, NH)
ppm. 13C NMR (75.4 MHz, DMSO-d6): d 123.4, 124.5, 125.8,
126.5, 126.9, 128.7, 128.8, 129.8, 134.7, 135.9, 142.6, 146.4,
147.8, 150.1 ppm. MS (FAB): m/z (%) 379 ([M+H]+, 100). HRMS
(FAB): m/z Calc. for C23H15N4S: 379.1017. Found: 379.1015. IR
C1: About 30.2 mg (7.85 ꢀ 10ꢁ5 mol) of 4a and 42.7 mg
(8.2 ꢀ 10ꢁ5 mol) of Ru(bpy)2Cl2 were used. Color: deep orange.
Yield: 73.9 mg (87%). Anal. Calc. for C41H28F12N8P2RuS2: C, 45.30;
H, 2.60; N, 10.30; S, 5.90. Found: C, 45.40; H, 2.80; N, 10.05; S,
5.85%. 1H NMR (CD3CN): d = 8.69 (s, 1H); 8.56 (t, 4H); 8.36
(d, 2H); 8.11 (m, 4H); 7.85 (m, 7H); 7.47 (m, 7H); 7.13 (m, 3H)
ppm. FD-MS: m/z 943.06 ([MꢁPF6]+), 797.08 ([Mꢁ2PF6ꢁH]+),
399.04 ([Mꢁ2PF6]2+). ESI-MS: m/z 943.2 ([MꢁPF6]+), 797.2
([Mꢁ2PF6ꢁH]+), 399.1 ([Mꢁ2PF6]2+). MALDI-TOF MS: m/z 797.6
([Mꢁ2PF6ꢁH]+), 641.6 ([Mꢁ2PF6-bpyꢁH]+).
(KBr, m
/cmꢁ1): 3439, 2950, 1605, 1562, 1531, 1479, 1451, 1429,
1395, 1351, 1312, 1296, 1259, 1212, 1190, 1119, 1069, 1029,
957, 844, 803, 740. Decomposition at T > 320 °C. UV (ethanol,
nm): kmax (log e) = 345 (4.16).
2.3.1.2. 2-(Furan-20-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (6a).
The compound was isolated as an orange solid (0.114 g, 85%). 1H
NMR (300 MHz, DMSO-d6): d 6.76–6.79 (m, 1H, 40-H), 7.25 (d,
1H, J = 3.0 Hz, 30-H), 7.78–7.82 (m, 2H, 5-H + 10-H), 7.99 (d, 1H,
J = 1.2 Hz, 50-H), 8.90 (d, 2H, J = 7.8 Hz, 4-H + 11-H), 9.02 (d, 2H,
J = 1.8 Hz, 6-H + 9-H), 13.93 (br s, 1H, NH) ppm. 13C NMR
(75.4 MHz, DMSO-d6): d 109.9, 112.5, 123.3, 129.6, 143.0, 143.6,
144.4, 145.4, 147.9 ppm. MS (FAB): m/z (%) 287 ([M+H]+, 100),
226 (5). HRMS (FAB): m/z Calc. for C17H11N4O: 287.09389. Found:
C2: About 24.3 mg (5.85 ꢀ 10ꢁ5 mol) of 4b and 32.0 mg
(6.15 ꢀ 10ꢁ5 mol) of Ru(bpy)2Cl2 were used. A few drops of ethanol
were added in order to increase solubilization of the ligand. Color:
deep orange. Yield: 29.3 mg (45%). Anal. Calc. for C42H30F12N8O-
P2RuS2ꢂ1.5C2H5OH: C, 45.55; H, 3.30; N, 9.45; S, 5.40. Found: C,
45.88; H, 3.40; N, 9.70; S, 5.85%. 1H NMR (CD3CN): d = 8.80 (d,
2H); 8.53 (m, 4H); 8.10 (t, 2H); 7.99 (t, 2H); 7.87 (m, 4H); 7.66
(d, 3H); 7.56 (m, 2H); 7.44 (t, 2H); 7.25 (t, 2H); 7.02 (d, 1H); 6.91
(d, 1H); 6.24 (d, 1H); 3.92 (s, 3H) ppm. FD-MS: m/z 973.03
([MꢁPF6]+), 827.07 ([Mꢁ2PF6ꢁH]+). ESI-MS: m/z 973.2 ([MꢁPF6]+),
827.2 ([Mꢁ2PF6ꢁH]+), 414.1 ([MꢁRu(bpy)2(PF6)2]ꢀ. MALDI-TOF
MS: m/z 827.6 ([Mꢁ2PF6ꢁH]+).
287.09274. IR (Nujol,
m
/cmꢁ1): 3396, 2923, 2853, 1644, 1565,
1538, 1507, 1463, 1397, 1377, 1350, 1228, 1191, 1116, 1073,
1017, 976, 897, 885, 807, 739. Mp = 122.3–124.5 °C. UV–Vis (etha-
nol, nm): kmax (log e) = 318 (4.14).
C3: About 30.5 mg (8.06 ꢀ 10ꢁ5 mol) of
5 and 44.1 mg
2.3.1.3. 2-(50-(Thien-200-yl)furan-20-yl)-1H-imidazo[4,5-f][1,10]phe-
nanthroline (6b). The compound was isolated as a dark yellow solid
(0.110 g, 79%). 1H NMR (400 MHz, DMSO-d6): d 7.03 (d, 1H,
J = 3.6 Hz, 30-H), 7.20–7.22 (m, 1H, 400-H), 7.33 (d, 1H, J = 4.0 Hz,
40-H), 7.60 (dd, 1H, J = 3.6 and 1.2 Hz, 300-H), 7.66 (dd, 1H, J = 5.2
and 0.8 Hz, 500-H), 7.79–7.86 (m, 2H, 5-H + 10-H), 8.89–8.94 (m,
2H, 4-H + 11-H), 9.03 (dd, 2H, J = 4.0 and 2.0 Hz, 6-H + 9-H),
13.89 (s, 1H, NH) ppm. 13C NMR (100.6 MHz, DMSO-d6): d 108.0,
112.3, 119.2, 123.1, 123.4, 123.5, 124.4, 125.9, 126.4, 128.3,
129.7, 131.9, 135.8, 142.5, 143.6, 143.7, 144.3, 147.9, 147.9,
149.8 ppm. MS (FAB): m/z (%) 369 ([M+H]+, 100), 226 (4). HRMS
(FAB): m/z Calc. for C21H12N4OS: 369.08048. Found 369.08046. IR
(8.47 ꢀ 10ꢁ5 mol) of Ru(bpy)2Cl2 were used. Color: deep orange.
Yield: 26.3 mg (30%). Anal. Calc. for C43H30F12N8P2RuSꢂ6H2O: C,
43.40; H, 3.55; N, 9.40; S, 2.70. Found: C, 43.35; H, 3.25; N, 9.40;
S, 2.55%. 1H NMR ((CD3)2CO): d = 9.21 (d, 2H); 8.89 (dd, 4H); 8.50
(d, 2H); 8.31 (m, 4H); 8.20 (m, 4H); 7.99 (d, 2H); 7.91 (dd, 2H);
7.83 (d, 2H); 7.66 (m, 3H); 7.55 (d, 1H); 7.42 (t, 2H); 7.20 (m,
1H) ppm. FD-MS: m/z 790.82 ([Mꢁ2PF6ꢁH]+). ESI-MS: m/z 937.3
([MꢁPF6]+), 791.3 ([Mꢁ2PF6ꢁH]+), 396.1 ([MꢁRu(bpy)2(PF6)2]ꢀ).
MALDI-TOF-MS: m/z 791.28 ([Mꢁ2PF6ꢁH]+).
C4: About 27.2 mg (7.99 ꢀ 10ꢁ5 mol) of 6a and 44 mg
(8.39 ꢀ 10ꢁ5 mol) of Ru(bpy)2Cl2 were used. An orange solid was
obtained. Yield: 72.2 mg (91%). Anal. Calc. for C37H26F12N8OP2Ru: